Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Management and Research, Diabetes and associated disorders, Pancreatic function and diabetes, and Diabetes Treatment and Management.
The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology
Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
Towards the standardisation of adult person‐reported outcome domains in diabetes research: A Consensus Statement development panel
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes
Artificial Intelligence and Machine Learning for Improving Glycemic Control in Diabetes: Best Practices, Pitfalls, and Opportunities
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes
<scp>C</scp> ontinuous glucose monitoring‐based <scp>time‐in‐range</scp> using insulin glargine 300 units/ <scp>ml</scp> versus insulin degludec 100 units/ <scp>ml</scp> in type 1 diabetes: The <scp>head‐to‐head</scp> randomized controlled <scp>InRange</scp> trial
Towards Achieving Equity and Innovation in Newborn Screening across Europe
Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe
Duo Research Archive (University of Oslo) 2022cited by 15position: middle
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1